Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.150
+0.650 (43.33%)
At close: Apr 15, 2025, 4:00 PM
2.190
+0.040 (1.86%)
After-hours: Apr 15, 2025, 6:37 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $67.41 million as of April 15, 2025. Its market cap has decreased by -58.93% in one year.
Market Cap
67.41M
Enterprise Value
-111.56M
1-Year Change
-58.93%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $67.41M, a decrease of -71.33%. That is a compound annual growth rate of -40.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2025 | 67.41M | -64.04% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |
| Thermo Fisher Scientific | 165.40B |
| Danaher | 135.03B |
| Stryker | 133.70B |
| Sanofi | 124.23B |
| Medtronic | 106.32B |
| McKesson | 86.39B |